Ventyx Biosciences, Inc. (VTYX) – Financial Analysis and Stock Price Prediction
Company Overview
- Company Name: Ventyx Biosciences, Inc.
- Ticker Symbol: VTYX
- Industry: Biotechnology
- Sector: Healthcare
- Website: https://ventyxbio.com
- Address: 12790 El Camino Real, Suite 200, San Diego, CA 92130, United States
- Phone: 760 593 4832
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates to address inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. Ventyx Biosciences is also developing other product candidates such as VTX002 for ulcerative colitis, VTX2735 for cryopyrin-associated periodic syndrome, and VTX3232 for CNS disorders.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
